Close

Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022

Go back to Guardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022
Textainer Group Holdings limited (NASDAQ: GH) Delayed: 20.29 +2.33 (12.97%)
Previous Close $17.96    52 Week High $5.84 
Open $18.20    52 Week Low $5.49 
Day High $20.30    P/E N/A 
Day Low $18.13    EPS $0.00 
Volume 4,159,097